Financial

Osteal raises $50m to bring joint infection drug/device combo to market (Medical Device Network) Osteal Therapeutics has raised $50m in

Congratulations to Implanet ! Implanet, founded in 2007 and based in Bordeaux, France. The company’s flagship products include the JAZZ®

In a series of articles, I predicted that generic orthopedic implants—proven designs replicated at a lower cost—would capture at least

In the wild, a lion can capture, kill, and eat a field mouse with ease. However, the energy expended to

A Scientific Approach to VC Finding defensible magic is hard. Completing your Ph.D. is hard. Building a company is hard.

Overview of Highridge Medical from Orthopedics This Week The Buyer Highridge Medical’s senior leadership are among the most experienced, successful,

 Study: Industry payment distributions may be skewed by 0.1% of physician earners (Healio) According to published results, industry payment distributions

I recently coined the phrase “Zombie Ortho Companies” and wrote about a particular Zombie Spine company called, Spineway. Spineway is

Congrats to Spineway ! Spineway was founded in 2005 in Lyon France.  Spineway is typical of hundreds of “me-too” spine

There is a recent trend where good people have found themselves in ortho companies with poor financial health. Often they

Discover how to build wealth in orthopedics by choosing emerging niches, collaborating with top talent, and balancing smart, strategic work.

I am officially announcing that Spine has reached its saturation point. There are the natural technology cycles in orthopedics. Once

websites – https://www.bostonoandp.com/ and https://www.orthopediatrics.com/ Tiger’s Initial Thoughts Orthopediatrics (OP) has acquired another “dog” using financial leverage and they will

ZIRP is the zero interest rate policy that has been the primary philosophy of US Central Bank since 2008. ZIRP

Henry Schein Enters Extremity Segment of Orthopedic Market Agrees to Acquire a Majority Interest in TriMed, Forms Strategic Relationship With

website – https://www.serf.fr/en/ Stryker to acquire joint replacement company SERF SAS (MassDevice) Stryker (NYSE: SYK)+ announced today that it executed a binding

Zimmer is a world-class total joint company that has tried to diversify into spine over and over again… and failed.

Early-Stage Investors: Seed and Angel Funding “Kind of when we first think about who are the earliest investors in companies,

This partnership will dramatically streamline the rollout of evidence-based protocols, automated clinical decision support, remote care management, and value-based care

If you recall in 2022, Bioventus planned to acquire CartiHeal for $450M (4X sales), but Bioventus spit them out –

Earlier this year I wrote about all the things that Treace is doing right here – Stepping into the future:

Wow! This is a big one! This big casualty resulted because of runaway expenses and lack of focus. Once again,

Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology

Takeaway Message: In 2024, look for DePuy-Synthes to spin out poor divisions and/or product lines and to acquire brand new

5 financial challenges facing the medtech sector (MedTechDive) As medical device leaders gather this week at AdvaMed’s annual Medtech Conference, several

Rebecca Whitney, President of ZimVie spine. The President of ZimVie Spine, recently conducted a Q&A session with MedTechDive, prompting me

Strange bed fellows! My initial thought is that Enovis made this acquisition for three reasons: 1) For the global reach

Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M (MedDevice) Boston Scientific(NYSE: BSX)+ announced today that it entered

We always assume that the next new sale is good business. More sales, more profit. But not all sales are

Here we go! It’s only been a week since the Conformis acquisition closing and Restor3d needs more capital. Not sure

Class action lawsuits like this help to make the case for single-use sterile instruments. At least one death, “hundreds of

In the dynamic realm of medical device startups, securing essential capital is a make-or-break endeavor that fuels innovation and progress.

In our dynamic world of orthopedics, external market financial trends can wield considerable influence on companies. These trends often operate

Augmedics may have just grabbed the deal of the century. A quick background and three thoughts. Background: Surgalign spent $125M

In the ever-evolving realm of orthopedics, a counterintuitive insight challenges conventional thinking: Owning the most advanced technology or best product

Why is Proprio important? The Proprio Paradigm technology has the potential to revolutionize orthopedic and spine surgery in a number

Orthopedic companies MUST learn financial discipline in order to survive. The easy capital faucet is was turned off forever back

In reading about the failure of ViewRay and thought that it was representative of how orthopedics companies have failed in

Websites… https://curvafix.com/ https://mvm.com/ CurvaFix raises $39M, announces new CEO (MassDevice) CurvaFix announced today that it closed a $39 million equity

Smart orthopedic startups use metrics to monitor the health of their business. Below are 11 useful metrics that software startups

This is one of the single best business ideas I’ve ever heard. Any orthopedic companies can use this tool. Ortho

Zavation, a Gemspring Capital Portfolio Company, Acquires CoreLink (press release) Zavation Medical Products, LLC (“Zavation”), an innovative designer and manufacturer

Restor3d to acquire Conformis for $2.27 per share (MassDevice) websites: https://www.restor3d.com/ https://www.conformis.com/ This ends the death spiral for Conformis. ConforMIS

Surgalign reached a market cap of $180M in May 2019. They posted $117M in gross sales in 2019. Four years